Código QR (código de barras bidimensional)

Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis

Tumor necrosis factor (TNF) inhibitors improved clinical outcomes for patients with psoriasis but are limited by their high cost. There are several biosimilar options approved for the treatment of psoriasis which provides a lower-cost alternative and the potential to increase treatment availability...

Fuld beskrivelse

Na minha lista:
Principais autores: Rachel C. Ruda, Katherine A. Kelly, Steven R. Feldman
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis Group 2023-12-01
Serier:Journal of Dermatological Treatment
Fag:
psoriasis
tnf-inhibitor
biosimilar
biological agents
Online adgang:http://dx.doi.org/10.1080/09546634.2022.2140569
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker